The majority of triple-negative breast cancers (TNBCs) which do not express estrogen receptor (ER), progesterone receptor (PR), and HER2 are basal-like, and many basal-like breast tumors are triple-negative; nevertheless, they are not equivalent in terms of gene expression profiles and immunohistochemical analyses [4]. This evidence concerns the gene ERBB2 and breast neoplasm.